Figure 2. Subgroup analyses of East Asians from randomized control trials about acute coronary syndrome. This figure was modified from the original version.⁵³⁾.

ACS = acute coronary syndrome; AMI = acute myocardial infarction; CI = confidence interval; DAPT = dual antiplatelet therapy; HR = hazard ratio; COMMIT/CCS-2 = Clopidogrel and Metoprolol in Myocardial Infarction Trial/Second Chinese Cardiac Study; CURRENT/OASIS-7 = Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS-7; PCI = percutaneous coronary intervention; PHILO = Study to Assess Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndrome; PRASFIT-ACS = PRASugrel compared with clopidogrel For Japanese patIenTs with ACS undergoing PCI; STEMI = ST segment elevation myocardial infarction; TRILOGY-ACS = TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes.